Oral Cancer News | Tag Archive | Food and Drug Administration

HPV vaccine myths put health, lives at risk, say health leaders: Airing the facts

Thursday, December 1, 2011

Source: TheNationsHealth.org Vaccination rates for human papillomavirus are lagging for teens, and a complicated web of confusion and misinformation may be to blame, according to public health leaders. Several strains of HPV can cause cervical cancer, and two vaccines, Gardasil and Cervarix, have been shown conclusively to defend against those strains. The Food and Drug [...]

Europe Bans X-Ray Body Scanners

Thursday, December 1, 2011

0 Comments

Source: AVWeb.com The European Commission decided in November to ban airport body scanning X-ray backscatter machines after studies found a small number of cancer cases linked to use of the devices. The decision affects all airports in Europe, with an exception for U.K. airports that will be allowed to test them, but not deploy them [...]

FDA Approves Cetuximab for Late-Stage Head and Neck Cancer

Wednesday, November 9, 2011

0 Comments

Source: The Oncology Report The Food and Drug Administration on Nov. 7 approved cetuximab as an initial treatment of late-stage head and neck cancer in combination with chemotherapy. Cetuximab, marketed as Erbitux by Bristol-Myers Squibb, is an epidermal growth factor receptor (EGFR) antagonist, administered as an intravenous infusion. Previously, it was approved in combination with [...]

Monitoring Tobacco-Specific N-Nitrosamines and Nicotine in Novel Marlboro and Camel Smokeless Tobacco Products: Findings From Round 1 of the New Product Watch

Monday, October 31, 2011

0 Comments

Source: OxfordJournals.org Abstract Introduction: Information on chemical composition of the new oral “spitless” smokeless tobacco products is scarce, and it is not clear whether there is some variability as a function of purchase place or time due to either unintended or intended manufacturing variations or other conditions. Methods: We analyzed tobacco-specific N-nitrosamines (TSNA) and nicotine [...]

Kentucky Cancer Center Urges Smokers to Switch to Smoke-Free Tobacco. But is it Really a Better Option?

Monday, October 31, 2011

0 Comments

Source: Yourlife.USAtoday.com In the smoker-heavy state of Kentucky, a cancer center is suggesting something that most health experts won’t and the tobacco industry can’t: If you really want to quit, switch to smoke-free tobacco. The James Graham Brown Cancer Center and the University of Louisville are aiming their “Switch and Quit” campaign at the city [...]

New HPV Study Proves Vaccine’s Effectiveness

Tuesday, September 27, 2011

0 Comments

Source: Cancer.gov A flurry of new research findings on a vaccine that prevents persistent infections by cancer-causing types of the human papillomavirus (HPV) has confirmed the vaccine’s efficacy and opened new avenues for research. The results, published in three separate reports, suggest that the vaccine could be simpler to administer and more affordable than researchers [...]

New Study for Cancer Patients to Help Improve the Body’s Ability to Fight Illness

Thursday, August 25, 2011

0 Comments

Source: Sign On San Diego A Santa Monica research center will test an experimental therapeutic filtering device being developed by Aethlon Medical on blood taken from cancer patients, the San Diego company said Wednesday. The study will target exosomes, bubbles of protein and RNA molecules excreted by cancerous cells that can block immune system cells [...]

Shortchanging cancer patients

Sunday, August 7, 2011

0 Comments

Source: nytimes.com Author: Ezekiel J. Emanuel Right now cancer care is being rationed in the United States. Probably to their great disappointment, President Obama’s critics cannot blame this rationing on death panels or health care reform. Rather, it is caused by a severe shortage of important cancer drugs. Of the 34 generic cancer drugs on [...]

Sanford researcher to study new oral cancer therapy

Saturday, July 16, 2011

0 Comments

Source: www.mdnews.com Author: public release A new Sanford clinical trial will study the safety and effectiveness of a drug treatment on patients receiving radiation and chemotherapy for head and neck cancer. About three to five percent of all cancers reported in the United States are head and neck cancers. Although the incidence of this type [...]

New labels may not go far enough

Sunday, July 3, 2011

0 Comments

Source: www.denverpost.com Author: Rhonda Hackett How far would you go to stop a killer? Smoking continues to kill more Americans every year than alcohol, AIDS, car accidents, illegal drugs, murders and suicides combined. Tobacco use remains the leading preventable cause of death and the single greatest driver of health-care costs in Colorado. Despite concerted efforts [...]

Tag Archive | "Food and Drug Administration"